Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cells|July 27, 2022
Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver TumorigenesisMargaret Tulessin, Rim Sabrina Jahan Sarker, Joscha Griger, et al.Pathologie (Heidelberg, Germany)|July 14, 2025
[Pathology of liver tumours in animal models]Thomas Metzler, Margaret Tulessin, Tanja Groll, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Preclinical Evaluation of Stable Integrin αvβ3-Specific [198Au]Gold Nanoparticles for Tumor TherapyGüllü Davarci, Carmen Wängler, Klaus Eberhardt, et al.Analytica Chimica Acta|October 10, 2025
Enhancing in-situ molecular profiling of gastric cancer for spatial proteomics through optimized digestionLydia Jung, Julius Shakhtour, Bianca Grosser, et al.Cancer Discovery|July 20, 2026
LPL-Positive Endothelial Cells Control T-cell Homing in Liver MetastasisXiaowen Zhang, Miki Kamiyama, Margaret Tulessin, et al.Frontiers in Immunology|July 23, 2026
Modular delivery of co-stimulatory signals through a PD-1-based immunoswitch receptor improves the functionality of Hepatitis B Virus-specific engineered T cellsLuis Felipe Olguín-Contreras, Johanna Heep, Lisa Schiller, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|September 18, 2025
Detailed Characterization and Comparison of Mouse Models for CholangiocarcinomaMargaret Tulessin, Ludwig Beer, Stephanie Roessler, et al.Frontiers in Immunology|March 30, 2026
Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody responseHélène A Kerth, Martin Kächele, Nikolas Müller, et al.Research Square|June 30, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseaseVolker Lohmann, Paul Rothhaar, Christian Heuss, et al.Nature Communications|December 7, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseasePaul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, et al.Pageof 2